X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare WYETH LTD with Torrent Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

WYETH LTD vs TORRENT PHARMA - Comparison Results

WYETH LTD    Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    WYETH LTD TORRENT PHARMA WYETH LTD/
TORRENT PHARMA
 
P/E (TTM) x 27.7 25.6 108.2% View Chart
P/BV x 5.3 6.3 85.2% View Chart
Dividend Yield % 1.3 3.2 40.0%  

Financials

 WYETH LTD   TORRENT PHARMA
EQUITY SHARE DATA
    WYETH LTD
Mar-13
TORRENT PHARMA
Mar-16
WYETH LTD/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1,0441,720 60.7%   
Low Rs8181,134 72.2%   
Sales per share (Unadj.) Rs298.6394.5 75.7%  
Earnings per share (Unadj.) Rs57.2101.8 56.2%  
Cash flow per share (Unadj.) Rs58.4116.3 50.2%  
Dividends per share (Unadj.) Rs17.0040.00 42.5%  
Dividend yield (eoy) %1.82.8 65.1%  
Book value per share (Unadj.) Rs249.5200.3 124.6%  
Shares outstanding (eoy) m22.72169.22 13.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.13.6 86.2%   
Avg P/E ratio x16.314.0 116.1%  
P/CF ratio (eoy) x15.912.3 130.0%  
Price / Book Value ratio x3.77.1 52.4%  
Dividend payout %29.739.3 75.6%   
Avg Mkt Cap Rs m21,157241,435 8.8%   
No. of employees `0000.510.9 4.5%   
Total wages/salary Rs m4008,559 4.7%   
Avg. sales/employee Rs Th13,787.46,129.6 224.9%   
Avg. wages/employee Rs Th813.0785.8 103.5%   
Avg. net profit/employee Rs Th2,643.31,581.3 167.2%   
INCOME DATA
Net Sales Rs m6,78366,764 10.2%  
Other income Rs m3532,156 16.4%   
Total revenues Rs m7,13668,920 10.4%   
Gross profit Rs m1,61727,204 5.9%  
Depreciation Rs m272,461 1.1%   
Interest Rs m61,859 0.3%   
Profit before tax Rs m1,93825,041 7.7%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-5-1,403 0.4%   
Tax Rs m6326,414 9.9%   
Profit after tax Rs m1,30117,224 7.6%  
Gross profit margin %23.840.7 58.5%  
Effective tax rate %32.625.6 127.4%   
Net profit margin %19.225.8 74.3%  
BALANCE SHEET DATA
Current assets Rs m6,98446,622 15.0%   
Current liabilities Rs m2,05632,843 6.3%   
Net working cap to sales %72.620.6 352.0%  
Current ratio x3.41.4 239.3%  
Inventory Days Days9974 133.7%  
Debtors Days Days2479 30.3%  
Net fixed assets Rs m24439,029 0.6%   
Share capital Rs m227846 26.8%   
"Free" reserves Rs m5,44131,400 17.3%   
Net worth Rs m5,66833,890 16.7%   
Long term debt Rs m2518,637 0.1%   
Total assets Rs m7,90190,136 8.8%  
Interest coverage x353.314.5 2,441.4%   
Debt to equity ratio x00.5 0.8%  
Sales to assets ratio x0.90.7 115.9%   
Return on assets %16.521.2 78.1%  
Return on equity %22.950.8 45.1%  
Return on capital %34.048.5 70.1%  
Exports to sales %0.243.3 0.5%   
Imports to sales %36.36.9 529.3%   
Exports (fob) Rs m1528,934 0.1%   
Imports (cif) Rs m2,4654,584 53.8%   
Fx inflow Rs m1529,185 0.1%   
Fx outflow Rs m2,6776,021 44.5%   
Net fx Rs m-2,66223,165 -11.5%   
CASH FLOW
From Operations Rs m92327,132 3.4%  
From Investments Rs m317-7,014 -4.5%  
From Financial Activity Rs m-481-14,352 3.4%  
Net Cashflow Rs m7595,767 13.2%  

Share Holding

Indian Promoters % 0.0 71.5 -  
Foreign collaborators % 51.1 0.0 -  
Indian inst/Mut Fund % 11.3 7.0 161.0%  
FIIs % 7.2 12.6 57.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 30.4 8.8 345.5%  
Shareholders   21,978 26,511 82.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare WYETH LTD With:   CIPLA  PIRAMAL ENTERPRISES  ALKEM LABORATORIES  SUN PHARMA  PFIZER  

Compare WYETH LTD With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Down 4.1%(09:30 am)

Asian stock markets opened mixed in early trade today. Hong Kong Hang Seng has advanced 143 points and China's Shanghai Composite has gained 9 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

WYETH LTD SHARE PRICE


Dec 9, 2014 (Close)

TRACK WYETH LTD

  • Track your investment in WYETH LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

WYETH LTD - ABBOTT INDIA COMPARISON

COMPARE WYETH LTD WITH

MARKET STATS